INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, ...
ROCHESTER, Minn.--(BUSINESS WIRE)--( plated )™ Skin Science, a breakthrough skincare brand powered by exosome science, today announced the opening of its new 14,000 square foot manufacturing facility ...
Exosomes Produced in the Liquid Media of the BioHarvest Unique Large-Scale Bioreactors Add Potential New Revenue Stream from Products and CDMO Opportunities Exosomes are nano-sized extracellular ...
New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of ...
ROCHESTER, Minn.--(BUSINESS WIRE)--RION, a clinical-stage regenerative medicine company at the forefront of exosome therapeutics, announced today the first subject was dosed in the Phase 2 clinical ...
TAIPEI, Dec. 30, 2025 /PRNewswire/ -- TOMO YUME Group today announced that its subsidiary, Sparkling Sciences, a leader in exosome research and development, has successfully obtained dual ...
Exosome-associated THSD7A is identified as a key trigger of filopodia formation in cancer cells and neurons, revealing a ...
This combination will create synergistic effects to boost the commercialization of exosome technology around the world. ExoCoBio will continue to support all the business activities currently engaged ...
Dr Batra's®, a pioneer of modern homeopathy in India, has introduced Dr Batra’s® XODerma, a breakthrough in skin rejuvenation ...
Exosomes Produced in the Liquid Media of the BioHarvest Unique Large-Scale Bioreactors Add Potential New Revenue Stream from Products and CDMO Opportunities Rehovot, Israel--(Newsfile Corp. - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results